Figure 3 | Scientific Reports

Figure 3

From: A study on factors influencing delayed sputum conversion in newly diagnosed pulmonary tuberculosis based on bacteriology and genomics

Figure 3

Drug resistance of Control and Case_Baseline Case_Treated groups. (A) Drug susceptibility test results of clinical isolates from the control group and the experimental baseline group; (B) Drug susceptibility test results of clinical isolates before and after 2 months of ATT (n = 18); (C) Drug susceptibility test results of clinical isolates before and after ≥ 5 months of ATT(n = 9). Anti-tuberculosis drugs with pink backgrounds are first-line drugs. Gray: drug-sensitive; Orange: MIC-only reported resistance; Green: MIC and WGS both reported resistance; Blue: only WGS reported resistance. Strains labeled with red are those reported as NTM by WGS.

Back to article page